Inosine regrows nerves in spinal cord injuries:
This article was originally published in Clinica
Administration of the nerve growth factor, inosine, to the motor cortex of rats with severed spinal cord motor nerve fibres led to nerve regrowth through the injury, researchers at Boston Life Sciences have reported. The Massachusetts-based company is developing growth factors for the treatment of spinal cord injuries and stroke, and now hopes to repeat the studies in nonhuman primates as a prelude to clinical trials.
You may also be interested in...
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.